Schroder Investment Management Group
ACET icon

Schroder Investment Management Group’s Adicet Bio ACET Stock Holding History

Schroder Investment Management Group’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-916
Closed -$892K – 1273
2019
Q3 		$892K Hold
916
– – ﹤0.01% 998
2019
Q2 		$1.05M Hold
916
– – ﹤0.01% 911
2019
Q1 		$700K Hold
916
– – ﹤0.01% 968
2018
Q4 		$884 Buy
916
+199
+28% +$262K ﹤0.01% 902
2018
Q3 		$1.22M Buy
+717
New +$935K ﹤0.01% 892

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Schroder Investment Management Group's ACET Position: Q4 2019 in Review

Schroder Investment Management Group sold out of Adicet Bio (ACET) in Q4 2019, closing a stake of 916 shares — an estimated $892K sold.

Schroder Investment Management Group first reported a position in ACET in Q3 2018 and held it in 5 quarters. The position peaked at $1.22M in Q3 2018. 54 funds tracked by Wall St. Rank hold ACET as of Q4 2019.

  • Schroder Investment Management Group reported no remaining Adicet Bio position as of Q4 2019 after selling out during the quarter.
  • Schroder Investment Management Group sold 916 Adicet Bio shares in Q4 2019, an estimated $892K.
  • Schroder Investment Management Group first reported a position in Adicet Bio in Q3 2018 and held it in 5 quarters.
  • Schroder Investment Management Group's Adicet Bio position peaked at $1.22M in Q3 2018.
  • 54 funds tracked by Wall St. Rank held Adicet Bio as of Q4 2019.

Based on Schroder Investment Management Group's 13F filing for Q4 2019, filed 11 Feb 2020.